May 9 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX)
VRX.TO said on Monday it expects to file its first-quarter
report with the regulators on or before June 10, ahead of the
July 31 deadline.
The Canadian drugmaker said it also expects the quarterly
filings for the second quarter ending June 30 and thereafter to
be filed on a timely basis with the Securities and Exchange
Commission and the Canadian Securities regulators.